Value of the "Test & Treat" Strategy for Uninvestigated Dyspepsia at Low Prevalence Rates of Helicobacter pylori in the Population

Helicobacter
Lars AgréusMichael Jones

Abstract

In populations with a low prevalence rate of Helicobacter pylori (H. pylori) infection from Western countries, guidelines for the management of uninvestigated dyspepsia generally recommend that the "test and treat" strategy should be avoided in favor of empiric proton-pump inhibitor therapy in younger patients (on average < 50 years of age) without alarm symptoms and signs. The prevalence of H. pylori infection has fallen from about 30% to about 10% in Sweden and other countries. We aimed to explore whether the rationale for test and treat is relevant in contemporary clinical practice. In settings with an infection rate in the adult population of 30% and 10%, we modeled the positive and negative predictive values for indirect (nonendoscopy) tests on current H. pylori infection with a presumed sensitivity and specificity of 95%. We then calculated the difference in false-negative and false-positive test outcome, and eradication prescription rates in the two scenarios. While the positive predictive value for the test decreased from 0.89 to 0.68 when the prevalence of H. pylori fell from 30% to 10%, there were only 1% more false-negative tests and 1% less false-positive tests. The eradication prescription rate would decrease by 18...Continue Reading

References

Aug 1, 1997·Epidemiology and Infection·T U KosunenO P Heinonen
Nov 24, 1999·The American Journal of Gastroenterology·P Moayyedi, A T Axon
May 20, 2000·Journal of Epidemiology and Community Health·S RosenstockO Bonnevie
Jul 27, 2000·Scandinavian Journal of Gastroenterology·C J LarkinD Buchanan
May 2, 2002·Gastroenterology·Brennan M R SpiegelJoshua J Ofman
Aug 17, 2002·Alimentary Pharmacology & Therapeutics·U LadabaumA M Fendrick
Feb 4, 2003·Alimentary Pharmacology & Therapeutics·P Sharma, N Vakil
Nov 16, 2005·Gastroenterology·Nicholas J TalleyPaul Moayyedi
Jul 19, 2006·Clinical Microbiology Reviews·Johannes G KustersErnst J Kuipers
Aug 24, 2006·Helicobacter·Katarzyna Dzierzanowska-FangratDanuta Dzierzanowska
Aug 24, 2006·Helicobacter·Masanori Hatakeyama, Tomasz Brzozowski
Jul 5, 2007·The American Journal of Gastroenterology·William D CheyUNKNOWN Practice Parameters Committee of the American College of Gastroenterology
Jul 5, 2008·The Journal of Infectious Diseases·Yu Chen, Martin J Blaser
Nov 10, 2009·Nature Reviews. Microbiology·Martin J Blaser, Stanley Falkow
Jan 12, 2010·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Lucio LombardoAndrea Chiecchio
Apr 12, 2012·Gut·Peter MalfertheinerUNKNOWN European Helicobacter Study Group
May 18, 2012·Alimentary Pharmacology & Therapeutics·B E LacyC Prather
Aug 10, 2013·Expert Review of Clinical Pharmacology·Sheila M WilhelmPramodini B Kale-Pradhan
Sep 23, 2014·Digestive Diseases and Sciences·Javier P GisbertAdrián G McNicholl

❮ Previous
Next ❯

Citations

Oct 4, 2019·BMJ : British Medical Journal·Emma SverdénJesper Lagergren
Feb 15, 2020·JGH Open : an Open Access Journal of Gastroenterology and Hepatology·Borathchakra OungCynthia W Ko

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.